No Data
No Data
No Data
No Data
No Data
Is Weakness In Porton Pharma Solutions Ltd. (SZSE:300363) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Porton Pharma Solutions (SZSE:300363) has had a rough three months with its share price down 26%. However, a closer look at its sound financials might cause you to think again. Given that fundamenta
Simply Wall StApr 13 20:52 ET
Porton Pharma Solutions Ltd. (SZSE:300363) Surges 9.2%; Individual Investors Who Own 39% Shares Profited Along With Insiders
Key Insights Porton Pharma Solutions' significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public The top 8 shareholders own 50%
Simply Wall StMar 18 02:23 ET
Boteng Co., Ltd. (300363.SZ): A total cost of 19.394,500 yuan to buy back 0.12% of the shares
Gelonghui Co., Ltd. (300363.SZ) announced that as of February 29, 2024, the company had repurchased 660,000 shares of the company's shares through a special stock repurchase securities account, accounting for 0.12% of the company's current total share capital. The highest transaction price was 32.00 yuan/share, the lowest transaction price was 27.01 yuan/share, and the total transaction amount was 19.3945 million yuan.
Gelonghui FinanceMar 4 04:14 ET
Boteng Co., Ltd. (300363.SZ): 2023 Employee Stock Ownership Plan to Complete Stock Purchase
Gelonghui, Feb. 27丨Boteng Shares (300363.SZ) announced that as of February 27, 2024, the 2023 employee stock ownership plan had purchased a total of 2,099,892 shares of the company's shares through centralized bidding transactions in the secondary market, accounting for 0.38% of the company's total share capital. The total transaction amount was 39,012,787.84 yuan, and the average transaction price was 18.58 yuan/share.
Gelonghui FinanceFeb 27 02:50 ET
Porton Pharma Solutions (SZSE:300363) Jumps 4.7% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns
Porton Pharma Solutions Ltd. (SZSE:300363) shareholders might understandably be very concerned that the share price has dropped 32% in the last quarter. But that doesn't change the fact that the re
Simply Wall StFeb 25 23:31 ET
Boteng Co., Ltd. (300363.SZ) plans to invest no more than 50 million yuan in the Xingze Phase IV Fund to lay out innovative life science enterprises
Boteng Co., Ltd. (300363.SZ) announced that the company plans to use its own funds to pledge an investment of no more than 50 million yuan to participate...
Zhitong FinanceFeb 23 05:42 ET
No Data
No Data